In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Streamline Health Solutions (STRM – Research Report). The company’s shares closed yesterday at $0.34.
According to TipRanks, Hewitt is an analyst with an average return of -3.9% and a 42.91% success rate. Hewitt covers the Healthcare sector, focusing on stocks such as Apyx Medical, Codexis, and Inotiv.
Currently, the analyst consensus on Streamline Health Solutions is a Moderate Buy with an average price target of $1.00.
See Insiders’ Hot Stocks on TipRanks >>
STRM market cap is currently $20.85M and has a P/E ratio of -0.98.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Streamline Health Solutions (STRM) Company Description:
Streamline Health Solutions, Inc. engages in the provision of transformational data-driven solutions for healthcare organizations. It solutions includes health information management (HIM), Coding and CDI; evaluator coding analysis platform; financial management; and patient care. It also offers audit, custom integration, training, electronic image conversion, and database monitoring services. The company was founded by J. Brian Patsy in October 1989 and is headquartered in Atlanta, GA.
Read More on STRM:
- Streamline Health Solutions Announces Leadership Change and Financial Restructuring
- Streamline Health Solutions Welcomes New Board Members
- Streamline Health’s Equity Securities Sale Impacts Investors
- Streamline Health Eases Loan Covenants and Updates Fiscal Targets
- Streamline Health Solutions Secures $4.4M in Financing Deal
